Treatment

MitoQ clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE2
MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis
The MARVEL study is testing a new drug, MitoQ, for ulcerative colitis flares. It aims to reduce inflammation and help the gut heal. This 24-week study compares MitoQ to a dummy pill in patients who also start steroids.
For: Ulcerative Colitis Flare
United Kingdom